SWISS PARENTERALS LIMITED Regd Office: 304 Samaan 2, Opp Shell Pump, Nr Prahladnagar road, Satellite, Ahmedabad , ,

Size: px

Start display at page:

Download "SWISS PARENTERALS LIMITED Regd Office: 304 Samaan 2, Opp Shell Pump, Nr Prahladnagar road, Satellite, Ahmedabad , ,"

Abel Rice
5 years ago
Views:

1 SWISS PARENTERALS LIMITED Regd Office: 304 Samaan 2, Opp Shell Pump, Nr Prahladnagar road, Satellite, Ahmedabad , ,

2 Nature of business Manufacturers and Exporters of sterile Injectables 1. Sterile Dry Powder Injectables - General 2. Sterile Dry Powder Injectables Betalactum Penicillin 3. Sterile Dry Powder Injectables Penems 4. Sterile Dry Powder Injectables Cephalosporins 5. Liquid small volume Parenterals in vials 6. Liquid small volume Parenterals in ampoules 7. Liquid small volume Parenterals in three piece eye ear drop 8. Liquid small volume Parenterals in pre filled syrinege

3 Factory address - Unit Kerala GIDC, Bavla, Ahmedabad , India Unit 2 402, Kerala GIDC, Bavla, Ahmedabad , India

4 Background - Company was originally incorporated in 1997, at Ahmedabad. In the past two decades Swiss Parenterals Ltd manufacturing enterprise producing quality pharmaceutical formulations. has grown to a Manufactures, formulation of injections (Dry Powder & Liquid) in form of Vials & Ampoules and Eye/ Ear/Nasal applications. Company exports as per the requirements in various countries like Kenya, Zimbabwe, Australia and Ukraine etc. Swiss supplies in bulk to Government hospitals as well as private hospitals on tendering basis. Company has been awarded tender for supply of its product from Madhya Pradesh Public Heath Services Corporation, Rajasthan Medical Services Corporation Limited, Odisha State Medical Corporation Ltd, Chhattisgarh Medical Services Corporation Ltd, Gujarat Medical Services Corporation Ltd. Is also one of the Contract Development and Manufacturing Organizations (CDMO). Manufactures various products for MNC s of India primarily for the exports. ISO-9001:2008 and ISO 14001:2004 certified for manufacturing & supply of pharmaceutical products small volume Parenteral. Accredited with WHO GMP certificates from Commissioner, Food & Drug Control Administration, Gandhinagar for Small Volume Parenteral. Unit II of the company has been awarded a G.M.P Certification for Good Manufacturing Practices by Australian Government. Recently, Unit II of the company has received GMP Certificate for registration in EudraGMDP.

5 EU GMP (Hungary) Certified

6 Current Organogram Board of Directors Managing Director General Manager Operation Manager QC QA Head Manager Production Engineer Purchase Manager Asst. Manager QC Microbiologist QA Executive Asst. Manager Production Head Administration PPMC Manager Executive QC Workman QA Officers Chemist Production Operator Incharge Ware House Officer Ware House Incharge Packing Officer packing Chemist QC (Chemical) Workman IPQA officers Workman Workmen Workmen Workmen/Women

7 Current R&D Organogram (individual function) BOD/MD Director (Projects and R&D) R&D Head Admin (Separate from regular) Analytical Manager Stability Manager Accounts and Purchase Officer 1 Officer 1 Data Entry Operators Trainee or Fresher Trainee or Fresher Helpers Helpers

8 Revenue Break-up Export v/s Domestic FY14 5.3% 0.7% 0.6% FY15 Domestic Sales 7.5% Domestic Sales Export ( Direct + Indirect) 44.1% 32.9% Export ( Direct + Indirect) Job work + Other Operating Income Non operating income 49.9% 59.0% Job work + Other Operating Income Non operating income FY16 5.5% 1.3% 6.8% 0.0% FY17 Domestic Sales Export ( Direct + Indirect) 30.9% 34.9% Domestic Sales Export ( Direct + Indirect) Job work + Other Operating Income Non operating income 62.3% 58.3% Job work + Other Operating Income Non operating income

9 Export Sales (58% to 62% of Turnover) Break-up to Top 5 Export Destinations FY16 FY17 10% 11% Philippines Kenya Nigeria Sri Lanka Ghana Rest of the World 11% 10% 11% 38% 9% 14% 23% 22% Kenya Philippines Nigeria Uganda Ghana Rest of the World 20% 20% Contribution of top 5 clients in Domestic Sales (31% to 35% of turnover) 53% 52% 51% 50% 49% 48% 47% 46% 45% 52% 48% 49% FY15 FY16 FY17

10 Financial Ratings CRISIL BBB BANK OF INDIA, MAIN BRANCH AHMEDABAD IS OUR ONLY BANKER FOR LONG TERMS NEEDS AND HAS GIVE US INVESTMENT GRADE RATING AND INTERNAL RATING IS AAA

11 Financial Snapshot Sales in Rs cr EBITDA Margin % 25.0% 20.0% 15.0% 10.0% 5.0% 15.4% 14.5% 19.0% 25.5% 0.00 FY14 FY15 FY16 FY17 0.0% FY14 FY15 FY16 FY % 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% PAT Margin 11.3% 6.7% 5.4% 1.5% FY14 FY15 FY16 FY17

12 Financials in Figures Income Statement FY14 FY15 FY16 FY17 Sales Other Income Total Sales Expenditure Material Consumed Employee Expenses Other expenses Total Expenses EBITDA Depreciation EBIT Interest Exceptional Items EBT Tax PAT Restatement Adjustment Restated PAT Balance Sheet FY14 FY15 FY16 FY17 Share Capital Reserves & Surplus Net Worth Long-term borrowings Deferred Tax Liability Current Liabilities Total Liabilities Fixed Assets Non Current Investment Deferred Tax Asset Long Term Loans & Advances Other Non Current Assets Current Assets Total Assets

13 Ratios

14 Manufacturing Units

15 QC labs HPLC Checmical GC Print check Stability Staff seating Media Preparations TOC APC

16 Certifications- Australia Cote D Ivorie EU Ethiopia Ukraine Ghana India Krgystan Kazkhstan Kenya Kosovo Namibia Nepal SGS ISO Sudan Tanzania Uganda PICS Zimbabwe

Medicamen Biotech Limited. Q1 FY19 Presentation July 2018

Medicamen Biotech Limited. Q1 FY19 Presentation July 2018 Medicamen Biotech Limited Q1 FY19 Presentation July 2018 Agenda Q4 Quarterly Highlights Financial Summary Strategy and Outlook Appendix Except for the historical information contained herein, statements